MEDICAL INSTINCT | CASE STUDY
SALE OF A MAJORITY STAKE TO A CONSORTIUM OF PRIVATE INVESTORS
An in depth-view on the successful, structured M&A process to arrange the succession of leading player in the German dental implant sector and unleash future growth.
Avalon advised the shareholders of Medical Instinct throughout the entire sales process to a consortium of Private Investors with ambitious growth plans for the Company.
Medical Instinct is a leading, international manufacturer of dental implantology and restorative dentistry solutions.
The Company has developed a variety of dental implants to cover a vast array of indications, while focussing on creating a fully digitalised workflow to support the conceptualisation of complex implant solutions.
Complementing the unique product portfolio, Medical Instinct offers surgical guides and equipment, offering a complete solution for dental professionals.
In combination with providing high-quality “Made in Germany” implant systems,
Medical Instinct supplies a distinctive services package to its clients, comprising a full suite of marketing solutions targeting dental practices and supporting them to attract patients.
With the value chain being fully covered by German partners, Medical Instinct is one of the last “Made in Germany” dental implant manufacturers underlining its unique market position and competitive advantage for medical practitioners as well as patients seeking the highest levels of usability as well as quality.
Founded in 2009 and headquartered in Bovenden (Central Germany), Medical Instinct employs a team of approximately 15 highly qualified employees.
The founders – Jan Worlitz and Marco Rhein - hired Avalon as their exclusive advisor to lead the M&A process and identify a suitable partner to unleash the proven growth potential as well as secure the continuity of the business.
GROWTH POTENTIAL
Together with its highly-qualified team, the founders wrote an impressive growth story since establishing Medical Instinct in 2009.
As a result, the entire M&A process has been defined by focusing on finding a partner, who would truly capitalise on the vast untapped growth potential on a national as well as international basis.
Being FDA as well as TFDA certified thereby theoretically enabling Medical Instinct to quickly establish a foothold in the United States - one of the most attractive and lucrative medical markets – as well as Taiwan providing an attractive inroad to the fast-growing Asian markets.
Domestically, Medical Instinct has relied on its stellar reputation, word-of-mouth and advocacy of renowned thought-leaders hence a partner with extensive experience in ramping-up a professional sales team will truly unleash the potential of the Company in the short- to medium term.
KEY TO SUCCESS
In light of the founders’ motivation to enter a professional M&A process, Avalon initially focused on truly understanding the motivation of all shareholders which combined finding a partner to accelerate growth as well as securing a smooth succession of the business operations.
Based on the sought-after market position and intellectual property, Avalon’s extensive network of national as well as international strategic buyers and financial investors (Private Equity and Family Offices) enabled us to present a broad array of potential partners.
Furthermore, a clear process structure as well as transparent communication with all involved stakeholders and investors is an important aspect for a successful process. Avalon Advisory is committed to always conveying a strong understanding of the process to all parties.
We see our advisory services as a partnership where each party plays an important role. We are continuously providing valuable information along each step of the process to make working together as easy and effective as possible.
Our process structure is aimed at creating momentum which contributes significantly to finding the right partner in the set time-frame. In doing so, we focus on expertise, economical factors as well as overall strategy.
Ultimately, we were driven to identify the ideal long-term partner to realise the untapped potential and provide promising perspective for the founders.
ACHIEVING THE BEST RESULT
Avalon Advisory ensures that the management team was neither distracted nor negatively impacted by the high-pressure environment of the process, always allowing the founders and their team to focus on the day-to-day business.
Acting as the exclusive sell-side advisor, Avalon Advisory was responsible for drafting all relevant investment documents, stakeholder communication, investor approach as well as leading the negotiations throughout the entire project.
As of August 2024, a consortium of private investors with deep industry know-how has acquired a majority share in Medical Instinct and is focusing on driving innovation as well as international growth of the Company.
CONTACT INFORMATION
Falk Ewaldsen
Managing Partner
falk@avalonadvisory.cc
+49 (0) 2054 87 357 94